[ May 11 (Fri) ]
IP Disputes and Countermeasures in Cell Therapies


We will present the latest trends in securing intellectual property rights in cell therapies including its technology commercialization and further discuss future IP strategies.


Session Chair Eunkyeong Lee, BKL
Time Session Title
10 : 00 ~ 10 : 30 Cellular Immunotherapy - IP Trends and Issues
Mi-Kyung Son, Senior Staff, Convergence Technology IP Team, PIPC(Patent Information Promotion Center)
10 : 30 ~ 11 : 00 US Intellectual Property Trends: Cell and Gene Therapy Products
Peter Kang, Associate, Legal, Wilson Sonsini Goodrich & Rosati
11 : 00 ~ 11 : 30 Cell therapy in Europe: an innovative technology requiring an innovative IP strategy
Robert Andrews , Partner, Patent Attorney, Biotechnology, Mewburn Ellis LLP
11 : 30 ~ 12 : 00 What Is Patentable in Australia? Recent IP Trends and Their Implications for Cell & Gene Therapy
Kieran Williams , Principal & Patent Attorney, Shelston IP
Panel Discussion
12 : 00 ~ 12 : 20
Mi-Kyung Son, Senior Staff, Convergence Technology IP Team, PIPC(Patent Information Promotion Center)
Peter Kang, Associate, Legal, Wilson Sonsini Goodrich & Rosati
Robert Andrews , Partner, Patent Attorney, Biotechnology, Mewburn Ellis LLP
Kieran Williams , Principal & Patent Attorney, Principal & Patent Attorney, Shelston IP